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The  existence  of a nutrient  sensitive  “autocatakinetic”  regulator  of embryonic  tissue  growth  has  been
hypothesised  since  the early  20th  century,  beginning  with  pioneering  work  on the  determinants  of  foetal
size by  the Australian  physiologist,  Thorburn  Brailsford-Robertson.  We  now  know  that the  mammalian
target  of  rapamycin  complexes  (mTORC1  and  2)  perform  this  essential  function  in  all  eukaryotic  tissues
by balancing  nutrient  and  energy  supply  during  the  ﬁrst  stages  of  embryonic  cleavage,  the  formation  of
embryonic  stem  cell  layers  and  niches,  the highly  speciﬁed  programmes  of  tissue  growth  during  organo-
genesis  and,  at  birth,  paving  the  way  for the ﬁrst  few  breaths  of life. This  review  provides  a synopsis  ofardio-pulmonary system
prouty2
the  role of  the  mTOR  complexes  in each  of  these  events,  culminating  in  an  analysis  of  lung  branching
morphogenesis  as a  way  of demonstrating  the  central  role mTOR  in deﬁning  organ  structural  complex-
ity.  We  conclude  that  the mTOR  complexes  satisfy  the  key  requirements  of  a nutrient  sensitive  growth
controller  and can  therefore  be  considered  as Brailsford-Robertson’s  autocatakinetic  centre  that  drives
tissue  growth  programmes  during  foetal  development.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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processes in developmental biology
Joseph Needham’s Chemical Embryology published in 1931 [1]
gives a fascinating and exhaustive perspective of the history
and cultural understanding of foetal development beginning with
Ancient Egyptian methods of artiﬁcial bird egg incubation through
to the rather lurid descriptions of foetal ﬂuids and membranes,
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ummarised in 1814 by J.F. John in his “Chemische Tabellen des
ierreichs”. At the time Needham’s book was published, much atten-
ion was given to deﬁning a universal quantitative formula for the
elationship between tissue size and foetal weight and Needham
omprehensively covered this debate arriving at a rather conﬂicting
et of conclusions:
i) Mitotic index falls with increasing age of the foetus,
yet, within this constraint,
ii) Different cells of the body mature and slow at different rates.
For all that, the gross pattern of foetal weight gain over time
shows,
ii) S-shaped kinetics that is characteristic of an endogenous
growth controller, a so-called “autocatakinetic” response.
This last view is probably the most interesting since it is the
rst acknowledgement that a critical control point governs the
ize of growing biological systems. The main proponent of this
autocatakinetic hypothesis” was Thorburn Brailsford-Robertson,
 Scots-born Australian, who in 1908 argued that “a master
eaction. . .would act as the limiting factor of growth, and would
mpress its own particular character on the general appearance of the
hole process from the outside”  [2]. With considerable foresight,
e argues that this master reaction would likely be an endoge-
ous cell regulator whose key characteristic being that it was
utrient sensitive and capable of directing the related processes
f what we now know to be gene expression and protein syn-
hesis, a concept dismissed by Needham as being “deﬁnitely out
f court”. It was therefore clear from the early 20th century that
ndividual cells possessed some kind of nutrient-sensitive regu-
ator of cell growth and differentiation; 83 years later, Heitman
t al. [3] made the link between rapamycin, a macrolide inhibitor
f cell growth produced by Streptomyces hygroscopius, and yeast
inases, target of rapamycin (TOR) 1 and 2 [4,5]. 4 years later a
ingle mammalian homologue was identiﬁed which shared the
utrient and rapamycin sensitive properties of its yeast ancestors
nd was ultimately named mTOR [6–8]. Thus, although modern
ay understanding of eukaryotic TOR signalling originated from
east biology, the philosophical origins of a nutrient sensitive
autocatakinetic” regulator of cell growth is ﬁrmly rooted in devel-
pmental biology and has a documented history that dates back
000 years to the beginnings of Egyptian agrarian civilisation and
ass food production. With this in mind, and as tribute to the fore-
ight of Brailsford-Robertson and his predecessors, the purpose
f this review is to identify the key roles played by mTOR dur-
ng embryogenesis and development. By taking the lung branching
orphogenesis programme as an example, we show how this
inase regulates the formation of complex organ structures by
mpressing “its own character on the general appearance of the whole
rocess from the outside.” [1].
. The initiation of protein synthesis and growth in the
ertilised oocyte
The ﬁrst moment of embryonic development begins with the
ontrolled reversal of metaphase II growth arrest in oocytes in
esponse to the acrosome reaction at the head of the sperm
hat enables gamete fusion and exocytosis of the sperm nucleus
nto the egg. In mammals, this event is coordinated by a series
f calcium signalling events which begin with the interaction
etween the sperm head and an oocyte surface matrix glyco-
rotein, zona pellucida 3 (ZP3 [9]). ZP3 stimulates production
f phosphatidylinositol-(3,4,5)-triphosphate in sperm membranes
nducing downstream Akt signalling (a regulator of mTOR but
nconﬁrmed in sperm) and release of phospholipase C, leading topmental Biology 36 (2014) 68–78 69
Ca2+ spikes in the oocyte which persist for hours after fertilisation.
These Ca2+ oscillations are necessary and sufﬁcient for orchestrat-
ing all fertilisation events including exit from metaphase II (MII)
arrest and the initiation of cell cycle activity and so can be thought
of as the cue that mediates the very ﬁrst induction of transcrip-
tion and translation. MII  arrest is sustained in quiescent oocytes
by activation of the cyclinB/cell division cycle protein 2 kinase
(cdc2) heterodimer, collectively known as maturation promoting
factor (MPF). This prolonged activity is unique to MII  and is main-
tained by a cytostatic factor (CSF) known as early mitotic inhibitor
2 (Emi2) which prevents the targeted degradation of cyclinB by
sequestering cdc20, an activator of the anaphase promoting com-
plex/cyclosome (APCC) ubiquitin ligase (Fig. 1). On fertilisation,
Ca2+ oscillations induce cyclic calmodulin kinase II (CamKII) activ-
ity which phosphorylates Emi2 at a RSST motif spanning amino
acids 192-5, inducing a strong interaction with polo like kinase-
1 (Plk1) leading to a secondary Emi2 phosphorylation within its
N-terminal phosphodegron domain (DSGXnS)[10,11]. In this con-
ﬁguration, Emi2 is ubiquitylated by SCF(TrCP) and its clearance
permits cdc20 to activate APCC and degrade cyclinB enabling the
ﬁrst mitotic cell division [10–15] (Fig. 1).
De novo protein synthesis is required to activate and then sus-
tain zygote gene expression and so represents a critical ﬁrst step
for initiating embryonic development [16]. Interestingly, the form
and character of protein expression is inﬂuenced by the frequency
and duration of Ca2+ spikes [17] raising the possibility that CamKII
transduces these events towards a programmed induction of trans-
lation. Since de novo gene transcription does not occur during
oocyte MII  arrest, the ﬁrst phase of protein synthesis occurs by
translation of mRNA derived from the maternal genome, retained
in the oocyte as stable dormant transcripts through sexual matu-
rity and ovulation. Cytoplasmic polyadenylation binding element
protein-1 (CPEB-1) plays a central role in this process by mediating
the silencing, storage or activation of maternal transcripts through
its interaction with 3′-untranslated mRNA regions. Studies in zebra
ﬁsh demonstrate that CPEB isoforms mediate a cascade of events
from initial activation of the transcriptome in the fertilised oocyte
through to the establishment of tissue patterns during embryo-
genesis [18]. A more detailed analysis of this cascade in fertilised
mammalian embryos revealed CPEB1 initiates a positive feedback
loop involving up-regulation of RNA binding proteins including
DAZL (deleted in azoospermia-like) whose expression is essential
for regulating other proteins involved in mitotic spindle assembly
and function [19]. CPEB-1 is also a calcium-activated CamKII sub-
strate whose phosphorylation in non-embryonic tissues has been
shown to promote its interaction with 3′ untranslated region (UTR)
of mRNA, induce its polyadenylation and so increase the efﬁciency
of gene expression [20,21]. Though yet to be demonstrated in 1-cell
embryos, this protein seems to show the type of acutely respon-
sive calcium-dependent regulation that could co-ordinate calcium
signalling intensity with the expression of distinct maternal mRNAs
as the ﬁrst step in protein synthesis.
Protein synthesis cannot occur, however, without ribosome
assembly and the initiation of a translational cap complex and so
CEBP-1 function must be partnered with regulators of this process.
mTOR is well established as the kind of nutrient-sensitive regula-
tor of cell growth which ﬁts beautifully with Brailsford-Roberson’s
concept of an “endogenous, nutrient-sensitive autocatakinetic
growth regulator”. mTOR forms the catalytic core of two dis-
tinct multi-protein complexes, mTORC1 (composed of mTOR,
mLST8/GL and regulatory-associated protein of mTOR (raptor))
and mTORC2 (mTOR, mLST8/GL and rapamycin-insensitive com-
ponent of mTOR (rictor)). mTORC1 displays acute sensitivity to the
mTOR inhibitor, rapamycin and phosphorylates the key proteins
in the initiation of ribosome assembly, (S6 kinase 1 (S6K1) and
translational initiation, eIF4E binding protein 1 (4EBP1)). mTORC2,
70 S.C. Land et al. / Seminars in Cell & Developmental Biology 36 (2014) 68–78
Fig. 1. Role of the mTOR complexes in the ﬁrst embryonic cell division. On fertilisation, the acrosome reaction induces PLC activity which initiates Ca2+ oscillations
in  the oocyte, the intensity and periodicity of which control the reversal of MII  arrest, genome activation, translation of oocyte transcripts and subsequence cell division.
The  schematic shows the Ca2+/CaM/CamKII pathway as an important mediator of these events which, 1) relieves MII  arrest by promoting a cascade of phosphorylation
events which culminates in APCC-dependent cyclin B destruction (see text for details) and, 2) activates the expression of maternal transcripts through phosphorylation of
CPEB-1  and its downstream regulation of DAZL (lower branch of ﬁgure: see text for details). Calmodulin/CamKII are known to induce mTOR complex signalling through
VPS34  and TSC2 pathways in other systems and, once active, may drive cap-dependent translation (mediated by 4EBP1 and S6K1), inﬂuence cell cycle activity (mTORC-1
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n  controlling translational activation and the close association between Ca2+ oscil
ignalling pathways that drives the ﬁrst cell division of life. The dotted lines highlig
n the other hand phosphorylates Akt/PKB at Ser473 and works
n tandem with phosphoinositide-dependent kinase 1 (PDK1)-
atalysed phosphorylation at Thr308 to induce full activation of
he enzyme [22]. Thus, mTORC2 regulates the involvement of
kt/PKB in cell proliferation, growth, survival, and metabolism. As
ith CEBP1, however, it is maternal mTOR transcripts and pro-
ein rather than de novo mTOR expression which drives protein
ynthesis through the ﬁrst cell division. This is demonstrated by
erm line knockouts of mTOR, mLST8, rictor or raptor which each
ail to prevent maturation of the fertilised oocyte from zygote
o blastocyst stages and only begin to disrupt embryonic growth
rom early implantation and beyond (E5.5 in mice) [23–25]. Inter-
stingly, experimental knockdown of either rictor or raptor in
ertilised mouse 1-cell embryos suggests that maternal mTORC1
nd mTORC2 may  play distinctly separate roles in the initiation of
he ﬁrst mitotic cleavage. mTORC1-dependent induction of S6K1-
389 phosphorylation appears necessary for MPF  degradation and,
ore generally, may  inﬂuence cdc2 activity during mitosis [26].
TORC2-mediated Akt/PKB Ser473 phosphorylation, on the other
and, is indispensable for the ﬁrst mitotic cleavage, acting through
ho GTPases to organise the mitotic cytoskeleton [27,28]. So how
ight mTOR complex activity be linked to the Ca2+ spikes that
nitiate the ﬁrst cell division of life? Evidence for direct CamKII reg-
lation of the type needed to co-ordinate mTOR signalling with
a2+ spike amplitude and frequency during and following fer-
ilisation is weak. Calmodulin (CaM), an essential component of
amKII activation, is known to interact with the carboxyl-terminus
f Tuberous Sclerosis Complex 2 (TSC2) which functions as an
pstream repressor of mTOR [29]. Mutation or deletion of this
ite repressed steroid/nuclear receptor transcription, however, the
iability of animal models carrying mutations that disrupt the
SC2 gene (the EKER rat, for example [30]) argues against a sig-
iﬁcant role for this mode of Ca2+-regulated mTOR function in
ocyte fertilisation. It may  be that other Ca2+-regulated inputs
o the mTOR pathway mediate the primary response of protein
ynthesis to Ca2+ spike amplitude and frequency. One strong can-
idate for this role is the class III phosphatidylinositol-3 kinase
PI3K) regulator, vacuolar protein sorting protein 34 (Vps34), thatisation during cell division (regulated by mTORC2). The central position of mTOR
 periodicity and genome activation implies a fundamental link between these two
didate signalling interactions that may be at the heart of this link.
phosphorylates phosphatidylinositol at the 3-position to produce
phosphatidylinositol-(3)-phosphate (PI(3)P), a membrane marker
for both intracellular trafﬁcking and autophagy [31]. In non-foetal
systems, increased nutrient availability (amino acids, for exam-
ple) has been shown to induce Ca2+ signalling and CaM binding
to Vps34 that is required for lipid kinase activity and increased
mTORC1 signalling [32,33]. Though unexplored in the context of
oocyte fertilisation, Vps34 may  be the missing link between Ca2+
spike amplitude, mTORC1 and translation that controls the ﬁrst cell
divisions of early embryonic life. Fig. 1 highlights the key roles of
mTORC1 and mTORC2 during the reversal of MII  arrest, initiation of
maternal RNA translation and organisation of the mitotic cytoskele-
ton and hypothesises VSP34 and TSC2 as possible links with calcium
oscillations which occur during fertilisation.
3. mTOR, stem cells and embryonic nutrient supply
A key implication of Brailsford-Robertson’s concept of auto-
catakinetic foetal growth regulation is that it must link nutrient
supply to the behaviour of stem cells in the ectodermal, endodermal
and mesodermal germ layers. This was one of the more controver-
sial hypotheses proposed at the time but we  now know that both
mTOR complexes regulate cell growth and autophagy in response
to various nutrient cues and so play key roles in determining
embryonic germ layer formation and the establishment of embry-
onic nutrient supply. Knockout studies show that endogenous
(i.e. foetal-derived) mTOR complex function supersedes maternal
mTORC1 and 2 activity during blastocyst development around the
time that inner cell mass (ICM) and trophectoderm cells proliferate
to form foetal germ layers and the placental interface respec-
tively. Guertin et al.’s [25] study of the effects of raptor, rictor and
mLST8/GL knockout demonstrated that all mTORC1 components
are essential for embryonic progression beyond the blastocyst stage
and die shortly after implantation (E5.5) whereas individual knock-
out of rictor or mLST8/GL tend to delay but not prevent further
embryogenesis (E10.5). This has led to a particular interest in the
role of mTORC1 as a critical link between the factors that control
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mbryonic stem cell proliferation, fate and nutrient supply to the
eveloping foetus.
Embryonic stem cells (ESC) grow from the inner cell mass (ICM)
o form the epiblast layer of the late blastocyst and participate
n a highly organised developmental process that establishes all
omatic foetal tissues. This begins before embryonic implanta-
ion into the uterine wall and is inﬂuenced by the hypoxic (PO2
13 mmHg), glucose-restricted but amino acid rich qualities of
terine ﬂuid [34–36]. mTOR, presumably in its mTORC-1 conﬁg-
ration, plays a critical role in maintaining ESC pluripotency and
roliferation by stabilising the transcriptional activities of Sox2,
ct-4 and NANOG, repressing cell cycle inhibition by cyclin G2
nd PDCD4 and expression of differentiation-promoting transcrip-
ion factors such as Mix1 homeobox-like 1 (MIXL1), T gene, and
he homeobox protein PITX2 [37]. Its inhibition promotes ESC lin-
age differentiation towards mesoderm and endodermal cell fates
ogether with an increase in cell motility and lowered rates of pro-
iferation; conversely, recovery of mTOR activity stabilises stem cell
luripotency. This places mTOR as a signalling hub that controls
he relationship between nutrient availability, ATP supply and the
etabolic demands of ESC growth (see [38] for a recent review). The
ubtlety of this relationship was recently demonstrated in a non-
mbryonic setting by Yilmaz et al. [39] who showed that mTORC1 is
ssential for transducing variation in calorie intake with intestinal
tem cell proliferation. In this system, Paneth cells at the base of the
ntestinal crypts act as paracrine regulators of neighbouring intesti-
al stem cells (ISC) through mTORC-1 regulated silencing of bone
tromal protein-1 (Bst-1) and cyclic ADP ribose (cADPR) release.
alorie restriction suppresses mTORC-1 activity and so relieves this
ilencing effect enabling paracrine cADPR induction of mTORC1 in
eighbouring ISCs which induces their non-differentiating prolif-
ration. The capacity of this system to link ISC proliferation with
alorie intake is profoundly illustrated in periodic feeders (Burmese
ythons, for example) which experience a near 5-fold increase in
illi length and doubling of gut mass within 24 h of ingesting a meal
40]. Whether a similar kind of process operates in ESC cells of the
lastocyst during early development in vivo is unknown, however,
oetal stem cell progenitors show a clear link between nutrient
vailability and proliferation versus determination of cell fate [41].
he evidence generally supports mTOR as an “autocatakinetic” cen-
re which links nutrient availability to stem cell proliferation and
luripotency in a number of systems including ESC.
. mTOR and the establishment of placental nutrient
ransport
Given its key role in nutrient sensing, calorie-monitoring and
he determination of embryonic cell fate, it is unsurprising that
TOR signalling is central to the development of the placenta as
he nutrient and gas exchange interface for the foetus. The placenta
evelops by penetration of trophoblast cells lining the perimeter of
he blastocyst into the uterine endometrium and involves staged
ransitions of trophoblast behaviour beginning with adhesion to the
terine epithelium, phagocytosis of the epithelial layer followed by
nvasion of the underlying decidual stroma. These events coincide
ith increased expression of the system B0,+ amino acid trans-
orter [42] which initiates trophoblast mTOR signalling by uptake
f leucine or arginine [43]. The mTOR complex constituent knock-
ut studies of Guertin et al. [25] conﬁrm the earlier observations
f Martin and Sutherland [43] that mTOR activation is essential for
rophoblast outgrowth and point towards a mTORC1-like protein
ssembly involving mTOR, raptor but not mLST8 as the main regula-
or of this process. Knockout of rictor and mLST8 only show lethality
t E10.5 well after the onset of placental nutrient exchange and sopmental Biology 36 (2014) 68–78 71
appear to be dispensable for trophoblast adhesion, migration and
proliferation.
mTOR plays varied roles in each staged transition of tro-
phoblast behaviour. Focal adhesion of trophoblast cells to the
uterine epithelium involves the expression of extracellular matrix
bridging proteins in both cell populations [44,45]. Of  the numerous
such proteins induced during the implantation period, the secreted
integrin receptor binding protein known as secreted phosphopro-
tein 1 (SPP1 or osteopontin) plays a particularly key role in directing
mTOR signalling among a plethora of integrin-speciﬁc responses
ranging from cell and ECM adhesion, cytokinesis and cell sur-
vival. SPP1 interaction with the trophoblast integrin heterodimer
aVb6 and uterine epithelial integrin aVb3 induces focal adhesion
molecule assembly that may  be particularly essential for stabilis-
ing embryo implantation and trophoblast invasion of the uterine
stroma [46]. From here, focal adhesion kinase (FAK) orchestrates
PI3K, Akt, mTOR, ERK1/2 and p38 MAPK signalling to regulate tem-
poral cell adhesion and cytoskeletal remodelling during cytokinesis
and trophoblast expansion [47,48].
mTOR is implicated during this time as a link between paracrine
and nutrient cues that inﬂuence trophoblast cell growth. Up-
regulation of glucose and amino acid transporters in trophoblast
cells and uterine epithelial cells by progesterone and secreted inter-
ferons induce cell proliferation by increases in mTOR signalling
and regulated genes in each of these compartments [49,50]. This
close link between nutrient transport, placental growth and mTOR
function explains why  maternal calorie intake or variation in pla-
cental metabolite exchange can lead to foetal growth insufﬁciency
or foetal hypersoma (gigantism) and further underscores the role
of mTOR kinase as a primary centre for co-ordinating nutrient and
growth signals in foetal and maternal compartments during preg-
nancy.
5. Gastrulation and early organogenesis
Gastrulation is the ﬁrst major morphogenetic event in embry-
onic development which establishes the distribution of the
mesoderm and endoderm layers that produce patterned body
axes. This process requires a balance between cell movement
across speciﬁc regions of the embryo followed by regulated growth
to establish the basic tissue architecture necessary for organ
development. The fundamental requirement for mTORC1 in early
embryonic growth masks the more subtle roles that this kinase
may  play in tissue patterning during gastrulation, however, sev-
eral signalling pathways that converge on mTOR are implicated in
the process. Fibroblast growth factor (FGF) signalling to tyrosine
kinase receptors is a fundamental aspect of foetal morphogenesis
and, in gastrulation, regulates mesodermal cell fate and cell cytoki-
nesis through ERK1/2-dependent regulation of the transcription
factor Brachyury and its genomic target, Wnt11 [51–53]. Polarised
cell movement induced by FGF also activates protein kinase C
(PKC) and the generation of Ca2+ waves to regulate localised Rho
GTPase activity and the outgrowth of cell protrusions [54–56]. Vari-
ations in ERK1/2 and PI3K signalling downstream of the tyrosine
kinase receptor, ErbB, act sequentially to regulate different aspects
of cell behaviour, with PI3K activity necessary for cell adhesion
and spreading whereas ERK1/2 drives cytokinesis [57]. Since PI3K
and MAPK pathways feed-back to one-another and input to mTOR
signalling, this hub acts as a co-ordination centre for the regula-
tion of cell movement and proliferation during gastrulation and
the beginnings of organogenesis.The relationship between PI3K and mTOR signalling in deter-
mining post-gastrulation cell fate is particularly well described
during neural tube development. Early studies demonstrated that
loss-of-function mutations in mTOR led to failure of forebrain
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xpansion in mice [58] whereas constitutive activation of mTOR
y loss of TSC2 caused excessive forebrain development [59]. This
ssociation between mTOR function, neuronal cell differentiation
nd population expansion explains the appearance of tuberous
rain projections that are composed of mixed cell phenotype in
uberous Sclerosis Complex (TSC) patients carrying mutations in
he mTOR repressor genes, TSC1 or 2 [60]. This suggests that tempo-
al and spatial mTOR activity in brain determines tissue patterning
nd cell fate during neuronal development. Neural tube develop-
ent is the earliest stage of neurogenesis in late gastrulation and
I3K-mediated signalling to mTOR inﬂuences the number and dis-
ribution of differentiated neurones during this process. Loss of
I3K signalling to Akt/PKB and mTOR by, for example, inactivation
f PDK1, results in fewer neurones and axon tracts whereas more
irect inhibition of mTOR using rapamycin maintains neuronal
rogenitor cell cycle activity but suppresses neuronal differentia-
ion and disrupts axon migration of ready-differentiated cells [61].
oreover, in an echo of the role played by mTOR in controlling
ntestinal stem cell turnover (Section 3), Love et al. [41] demon-
trate that mTOR acts as a nutrient dependent restriction point that
etermines the proliferation-differentiation programme of neuron
eplacement in the foetal retina. Here, slow stem cell growth gives
ise to a limited number of progenitor cells that undergo rapid
xpansion and neuronal differentiation. mTOR inhibition caused
y nutrient deprivation exclusively blocks the proliferation and
ifferentiation of progenitor cells without affecting the stem cell
opulation. This suggests a nutrient-sensitive restriction point bal-
nces nutrient availability with neuronal cell turnover but does not
eopardise overall regenerative capacity by preventing stem cell
rowth. By implication, Brailsford-Thompson’s “autocatakinetic”
entre resides exclusively at the level of mTOR activity in progenitor
ells that are primed for proliferation and differentiation and is not
ocated in the basal stem cell population. This characteristic is vital
or the sustained growth of complex tissue structures for it retains
 reservoir of founding stem cells whilst simultaneously commit-
ing a sub-population of progenitors, primed by mTOR signalling,
o speciﬁc differentiation programmes.
. mTOR and the development of tissue complexity: lessons
rom the branching morphogenesis programme of the lung
From gastrulation to birth, foetal organs undergo highly spec-
ﬁed programmes of growth and morphogenesis involving the
eneration of new tissue layers, folding, physical twists and changes
n size proportions. This is perhaps best exempliﬁed by the inter-
ependent growth of the lung airway and vascular system which
evelops as a semi-fractal, branched network of endoderm- and
ateral plate mesoderm-derived tubules that ultimately converge at
he alveolar blood-gas barrier. Weibel and Gomez [62] were among
he ﬁrst to measure the fractal branching pattern of the airways
oting that the decrease in airway diameter for each new branch
eclined by a constant factor (0.85 as re-analysed by Mauroy et al.
63]). This fractal scaling factor, referred to here by the Greek sym-
ol, , is slightly shallower than the predicted “optimal” rate (0.79)
uggesting that there is a built-in excess of dead space within the
irways which accommodates physiologic change in airway diam-
ter due to exercise, inﬂammation or disease [63].
The pulmonary vasculature closely follows the course of the
onducting airways, sharing the same rate of branching and tubu-
ar diameter decline up to the 15th branch generation. Beyond this,
ascular branching diverges at a greater rate proceeding through
8 generations to create the microvasculature surrounding each
lveolus [64]. The outcome of this branching morphogenesis pro-
ramme  is a compact, yet high gain-of-structure, low resistance
as exchange system of truly colossal proportions: in the airway,pmental Biology 36 (2014) 68–78
23 branch generations form a conducting network consisting of 17
million branches generating a combined length and gas exchange
surface area of 7 km and 130 m2 respectively, yet the pathway for
gas movement from atmosphere to alveolus is not more than 45 cm;
these impressive dimensions are eclipsed, however, by the pul-
monary vasculature whose fractal pattern and accelerated rate of
tubular branching in the gas exchange region of the lung generates
an estimated total length of 2–6 thousand km [65].
6.1. The airway branching process
Is there a role for mTOR in the pacing and coordination of
this branching morphogenesis programme? Airway outgrowth is
induced by ﬁbroblast growth factor-10 (FGF-10) which is secreted
from discrete regions of the mesenchyme ahead of each prospec-
tive airway branch. On contact with the airway epithelium the
tyrosine kinase ﬁbroblast growth factor receptor-2b (FGFR2b) stim-
ulates airway tube elongation towards the FGF-10 signal and
so, as the branch grows, a gradient of FGF-10 extends from the
growing tip towards the proximal point of each branch [66].
mTORC1 is active among the epithelial progenitor cells at the
tip of the airway that are closest to the FGF-10 induction sig-
nal. Treatment of nascent lungs with rapamycin consequently
blocks cell cycle activity in this region and, in an echo of the sig-
nal dampening that produces a controlled reduction in size for
each subsequent branch generation, raises non-proliferative air-
way branching so that the dimensions of each new branch become
disproportionately small [67]. Thus mTORC1 activity inﬂuences
both forward elongation of the airway as well as the branching
process.
The duration of forward growth is determined by feedback
mechanisms involving sonic hedgehog (Shh) whose secretion from
the advancing epithelial tube inhibits FGF-10 expression in the
mesenchyme immediately in front of the airway bud causing
this induction signal to move laterally, and Sprouty2 (Spry2), an
endogenous regulator of FGFR2b downstream signalling. Little
is known about the links between mTOR and Shh signalling in
lung although associations between these pathways have been
shown in other contexts. In brain, for example, Shh directs neuro-
genic patterning of the developing cerebellum by locally increasing
expression of one mTOR substrate (eukaryotic initiation factor 4E
(eIF4E)) and suppressing the activity of another (S6K1). Here, Shh
gradients set the stage for neural precursor proliferation in some
areas of brain and neural differentiation in others [68]. In cancer,
Shh and mTOR may  also act co-operatively to increase prolifera-
tive growth under conditions where TSC2-mediated inhibition of
mTOR and the cell cycle checkpoint protein p27kip1 is defective
[69]. In lung development, shh has an additional role to play in
regulating canonical growth factor signalling through bone mor-
phogenetic protein 4 (BMP4), followed by noggin, that establishes
the pattern of parabronchial smooth muscle deposition around
the airway tubes [70]. It is tempting to speculate that the kind
of shh-mTOR signalling seen in brain development can contribute
to this process in lung and, indeed, may  drive the pathologi-
cal deposition of pulmonary smooth muscle seen diseases linked
to sustained mTOR signalling such as lymphangioleiomyomatosis
(LAM) [71].
Spry2 plays a much more direct role in delineating airway
epithelial tubular growth patterns in response to FGF-10/FGFR2b
signalling. Spry2 is well known to antagonise tyrosine receptor
kinase signalling to ERK1/2 and its knockout in lung results in
airway epithelial branching defects [72–74]. Its activation cen-
tres on a conserved N-terminal tyrosine residue at position 55
(Y55) whose phosphorylation by FRS2-activated Src kinase [75]
is necessary for its interaction with both protein phosphatase 2A
(PP2A) and the ubiquitin ligase, cCbl (reviewed [76]). Although
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Fig. 2. The molecular basis of  in the airway branching programme of the lung. Temporal and spatial interactions between FGF-10, epithelial FGFR2b, Spry2 and sonic
hedgehog (Shh) establish the fractal patterning of airway branching. Each signalling cycle proceeds as follows: 1) The concentration of FGF-10 secreted from mesenchyme cells
ahead  of prospective airway branches determines the duration of FGFR2b activity in the epithelial cells of the airway tube (yellow indicates FGFR2b-active airway epithelial
cells).  2) FGFR2b evokes Spry2 activation, observed as loss of Spry2 stability as upstream inducers of ERK1/2 (e.g. Grb2, [76]) or repressors of mTORC1 (e.g. TSC2, [67]) form
complexes with the Spry2-cCbl ubiquitin ligase and are targeted for degradation. The result is antipodal regulation of ERK1/2 and mTORC1 (note that this mechanism is
unlikely to be reproduced by experimental Spry2 knockdown (e.g. [73,74]). 3) Tubular outgrowth occurs when Spry2 is destabilised (active) promoting epithelial mTORC1
activity and suppressed ERK1/2 activity. Conversely, branching epithelial growth is promoted when Spry2 is stable (inactive) and ERK1/2 activity is at its height, promoting
re-orientation of the spindle angle from the longitudinal axis of growth (see [74]). 4) Secretion of Shh from airway epithelium induced as a consequence of sustained FGFR2b
activation suppresses the production of FGF-10 ahead of the growing airway tube causing the FGF-10 signal to move laterally and promote a new cycle of growth. 5) A scaling
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lactor,  , whose complete molecular identity is currently unknown, dampens the r
ractal pattern of the conducting airways of the lung.
he precise mechanism of Spry2 activation remains uncertain,
t seems that PP2A de-phosphorylates two serine residues in a
erine rich region of the protein (Ser115 and Ser118) to induce a
onformational change that reveals a proline rich tail capable of
inding SH3 domain containing proteins and their partners [77].
y acting as an adaptor protein for the cCbl ubiquitin ligase, Spry2
herefore targets speciﬁc cell signalling components for ubiqui-
ylation and degradation. In airway epithelium, FGF-10 promotes
pry2 association with the FRS2/Grb2/Raf signalling complex and
isrupts signalling to ERK1/2 by targeting Grb2-associated pro-
eins for proteasomal destruction [76–79]. However, under the
ame conditions, Spry2 also forms a complex with TSC2 and cCbl
hich induces Rheb-GAP activity and so promotes mTORC1 activity
hat is coordinated with the airway branching process [67]. Thus,
ar from simply antagonising tyrosine kinase receptor signalling,
pry2 acts as a FGF-10-regulated switch that partitions signalling
etween mTORC-1 and ERK1/2 and so plays a crucial role in linking
he airway outgrowth cues with downstream growth responses,
 central feature of any molecular regulator of fractal growth.
ecent work has developed the airway branching model further
y showing that ERK1/2 activation increases the mitotic spindle
ngle of epithelial cells away from the longitudinal axis of tubu-
ar growth. Spry2 therefore functions to orchestrate proliferative
orward growth associated with mTORC1 activation and lateral
ranching growth associated with ERK1/2 signalling along the FGF-
0 gradient [67,74]. By extension, the interaction between FGF-10,
GFR2b, Spry2 and Shh and downstream effects on TORC1 and
RK1/2 activity can be described as part of the branching periodic-
ty “clock” mechanism that drives branching morphogenesis of the
irways and which acts as a molecular engine that deﬁnes  in the
ung (Fig. 2).signalling through this cyclical pathway with successive cycles and establishes the
6.2. The vascular branching process
Vascular growth follows the airway branching programme and
is initiated by the secretion of vascular endothelial growth factor-
A (VEGF-A) from the epithelial cells of the advancing airway tube.
VEGF-A gene expression is regulated at multiple levels (transcrip-
tion factor binding at a 1.2 kb (mouse, rat) to 2.362 kb (human)
5′ promoter region; mRNA stability through protein interaction
with its 3′ untranslated region; mRNA translation via internal ribo-
some entry site (IRES) sequences in the 5′ UTR) and is intrinsically
sensitive to external factors such as oxygen and growth factors
(reviewed [80]). Low oxygen tensions are a persistent feature of the
foetal environment, ranging from 0 to 13 mmHg during embryonic
implantation to ∼30 mmHg  throughout gestation (reviewed, [81]).
Raising oxygen partial pressures beyond this range inhibits vascular
growth [82] and is a contributing factor to neonatal conditions such
as bronchopulmonary dysplasia. Oxygen-sensitive VEGF-A expres-
sion is regulated by hypoxia inducible factor (HIF) binding to a HIF
consensus site (TACGTGGG) located in the 5′-proximal VEGF-A pro-
moter. HIFs are heterodimeric transcription factors comprising an
oxygen regulated  subunit and a nuclear translocating  subunit.
In hypoxia, the  subunit is stabilised, dimerises with the  subunit
and is translocated to the nucleus by association with the mem-
bers of the nuclear importer family, importin 1, 3, 5 or 7 [83].
Three HIF isoforms are expressed in the developing lung. HIF-
1 occurs in the branching airway epithelium and its homozygous
knockout in mice causes developmental failure of the vascula-
ture and death by E10.5 [84]. HIF-2  occurs in the epithelium
and interstitium and its knockout produces vascular defects during
alveolar septation [85]. HIF-3 is a truncated isoform that lacks the
C-terminal transactivation domain necessary for interaction with
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Fig. 3. mTORC1 and the co-ordination of airway and vascular growth in the foetal lung. Modiﬁed from Scott et al. [64] (with permission) to reﬂect the varied mTORC1
inputs into HIF-1 signalling and VEGF-A production [94,102]. Dotted arrows indicate pathways inferred from non-developmental systems. Right hand panel shows an
embryonic stage rat lung where perfused vasculature can be seen surrounding the airway branches and proximal to the airway tip (red hue in expanded image). Signalling
in  three zones of airway and vascular growth (A, B and C) are indicated: Zone A: FGF-10 is expressed in the mesenchyme ahead of nascent airway buds and diffuses towards
the  airway epithelium. Zone B: FGF-10 induces FGFR2b autophosphorylation and signalling to Spry2 whose activation inhibits signalling to the ERK1/2 pathway and also
induces TSC2 clearance enabling Rheb to bind GTP and activate mTORC1. Zone C: HIF-1, maintained stable by the low oxygen partial pressure of the foetal environment, is
regulated through the FGF-10-Spry2-mTORC1 signalling axis by a direct interaction involving the putative FVMVL TOS motif between amino acids 99–103. In addition, it is
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eikely  that HIF1 transcription and translation is augmented by: i) phosphorylation
f  4E-BP1 and S6K1. These mechanisms are also implicated in VEGF-A transcription
300/CBP and so is thought to act as a competitive repressor of
IF-1 and 2 activity [86]. Thus, HIF-1 plays the primary role in
ontrolling vascular signalling during lung development, whereas
IF-2 function is predominantly associated with the maturation
f vascular structures and the generation of the blood-gas barrier
87]. Although growth factors are well known to regulate VEGF-
 expression through other transcription factors (e.g. STAT3, Sp1,
P2; [80]), it seems that HIF-1  and 2-dependent regulation of
ascular growth and blood vessel maturation is critical for generat-
ng the type of vascular growth, reported by Lazarus et al. [88], that
s necessary for three dimensional lung branching. Proline hydrox-
lase domain (PHD) proteins critically regulate HIF-1–3 stability
uring lung development, as their inhibition augments HIF target
ene expression and promotes blood vessel growth and formation
f the blood gas barrier [89–91]. Of the three PHD isoforms, how-
ver, PHD2 appears to exert primary regulation of HIF-1 as its
nockdown exclusively induces HIF-signalling activity and gene
xpression in normoxia, whereas knockdown of PHD1 and 3 does
ot [92]. Although airway and vascular development is supported
etter at foetal rather than postnatal PO2, and hyperoxia causes vas-
ular defects due to silencing of the HIF signalling system, oxygen
radients around the airway tip are too shallow to direct localised
IF regulation of VEGF-A (∼15 mmHg: difference between the PO2
f the umbilical vein (30 mmHg) and the amniotic ﬂuid (15 mmHg;
93]). The low PO2 of the foetal environment therefore primes the
IF system by stabilising the -subunit with local regulation medi-
ted by the growth factors and repressors of the airway branching
eriodicity “clock” mechanism that drives branching morphogen-
sis (Fig. 3).AT3 at Y705 and the mTORC1 substrate site S727 and/or ii) co-operative activation
ranslation. Fg, foregut; Tr, trachea; RL, right lung lobules; LL, left lung lobules.
6.3. mTOR and the co-ordination of airway and vascular
branching
Scott et al. [67] investigated the mechanism that links the FGF-
10 airway growth cue with HIF-1  driven VEGF-A secretion in
foetal airway epithelial cells. When foetal airway epithelial cells
were cultured at the low PO2 that naturally reﬂect the foetal lung
environment, FGF-10 augmented HIF-1  activity above the level
produced by hypoxia alone, was kinetically matched by Spry2
destabilisation and mTORC1 activation and was  entirely abolished
by rapamycin. mTORC-1-dependent ampliﬁcation of HIF-1  activ-
ity is widely observed in response to growth factor cues and has
been demonstrated in primary and cell line culture systems with
widely ranging phenotypes. A functional interaction between the
Raptor scaffold protein of mTORC1 and the N-terminus of HIF-1
has been reported to amplify basal hypoxic induction of HIF-1
by increasing its interaction with the transcriptional co-activator
CBP/p300 [94]. Raptor binds mTORC1 to its substrates by inter-
acting with conserved penta-peptide sequences known as mTOR
signalling (TOS) motifs (FDL/IDL and FEMDI within S6K1 [95] and
4E-BP1 [96,97] respectively). Mutation of the highly conserved
phenylalanine at position 1 of the TOS motif prevents mTOR binding
and subsequent phosphorylation of its target residues. In an echo
of this, a TOS-like dependency for a series of residues between 99
and 103 of HIF-1  (FVMVL) is necessary for growth factor-sensitive
regulation of HIF-1 transcriptional activity [67,94,97]. In this case,
alanine mutation of the leading phenylalanine residue retains the
hypoxic induction of HIF activity but abolishes growth factor regu-
lation of this transcription factor and its efﬁcient interaction with
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Fig. 4. mTORC1 and mTORC2 play discrete roles in glucocorticoid- and growth factor-induced epithelial Na+ transport. Glucocorticoids (cortisol) activate Na+-driven
ﬂuid  clearance from the lung at birth. This schematic illustrates the central role of the mTOR complexes in linking growth factor and glucocorticoid pathways to the expression
and  membrane translocation of the ENaC subunits. Here, cortisol induces transcription of SGK1 and , ,  ENaC subunits whose translation is subject to regulation by mTORC1
signalling to 4EBP1 and S6K (not shown). Simultaneous activation of PI3K signalling induces ENaC subunit trafﬁcking to the membrane through a process that involves mTORC2
and  PDK1 at two points: 1) Akt/PKB phosphorylation at S473 (by mTORC2) and T308 (by PDK1), and 2) SGK1 phosphorylation at S422 (by mTORC2) and T256 (by PDK1).
Dual  phosphorylation of SGK1 induces an inhibitory phosphorylation of the Nedd4/2 ubiquitin ligase and so promotes ENaC trafﬁcking to the cell membrane [111–114]. At
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mirth,  ENaC opening increases Na+ absorption from the lung lumen, promoting ﬂuid
BP/p300 [67,94]. Thus, spry2 mediated mTORC1 may  link air-
ay outgrowth with vascular signalling by directly controlling the
fﬁciency with which the HIF-CBP/p300 transcriptional complex
atalyses histone deacetylation and DNA de-condensation along
he VEGF-A gene.
A number of alternative modes of HIF-1 regulation by mTORC1
ave also been proposed including: 1) stabilisation of HIF-1 [98],
) regulation of HIF-1 mRNA translation by 4E-binding protein
 (4E-BP1) [99] or ribosomal protein S6 kinase 1 (S6K1) [100]
nd 3) feedback regulation of mTORC1 regulation of HIF-1  by
EDD1 (regulated in development and DNA damage responses 1),
 hypoxia-inducible factor-1 target gene [101]. Dodd et al. [102]
ave consolidated these diverse inputs into HIF-1  signalling by
xploring the association between mTORC1 and its downstream
egulation of 4E-BP1, S6K1 and the signal transducer and activator
f transcription-3 (STAT3) transcription factor. They demonstrate
hat, whilst HIF-1  translation rate and protein abundance are set
y mTORC-1 regulated co-operative signalling to 4E-BP1 and S6K1,
rowth factor (insulin)-regulated HIF-1  transcription is driven
y STAT3, ready-primed by phosphorylation on Tyr705 (by, for
xample, ciliary neurotrophic factor [103,104]) to enable mTORC1-
ependent ser727 phosphorylation and HIF-1  transcription. Thus
TORC1 signalling inputs into STAT3, 4E-BP1 and S6K1 orchestrate
IF-1 and VEGF-A gene expression by controlling the overall efﬁ-
iency of HIF-1 transcription and protein translation. Perhaps the
ost signiﬁcant implication of this study is the emerging evidence
or several mTORC1-mediated inputs into VEGF-A gene expression,
or STAT3 interacts co-operatively with HIF-1 at the VEGF-A pro-
oter to drive VEGF-A expression and angiogenesis [80,105,106].ance from the lung and the ﬁrst breaths of life.
The FGF-10-Spry2-mTORC1-STAT3/HIF-1-VEGF-A signalling
axis represents an essential link between the processes of airway
and vascular branching morphogenesis and the current evidence
supports a role for mTORC1 in, i) regulating patterns of cell pro-
liferation at the airway tip, ii) inﬂuencing branching rate and
tubular size and, iii) potentiating the HIF-1 system to drive VEGF-
A expression according to the magnitude and distribution of the
FGF-10 airway outgrowth cue. These concepts are encapsulated in
the model proposed in Fig. 3 which places the interaction between
Spry2 and mTORC1 at the centre of the signalling pathway that
deﬁnes co-ordinated airway and vascular growth in the lung.
7. mTOR, birth and the onset of pulmonary gas exchange
In addition to its stem cell niche and organ structural roles,
mTOR controls physiological ion transport events in the pulmonary
epithelium which are essential for the foetus to complete the tran-
sition from placental to pulmonary gas exchange at birth. Fluid
secretion into the airways during development provides a distend-
ing pressure which supports the formation of the three dimensional
structure of the lung. This is rapidly cleared at birth by a corti-
sol and catecholamine-driven Na+ absorption process [107,108]
that regulates the expression, assembly and membrane insertion
of epithelial Na+ channel (ENaC) , , and  subunits (e.g. [109]).
Consequently, factors that prevent the proper membrane trafﬁc-
king and assembly of these subunits as a functional Na+-selective
ion channel cause perinatal respiratory distress and risk of death
due to ﬂuid retention in the lung (reviewed [110]). Serum gluco-
corticoid kinase-1 (SGK1) is a PI3K-regulated component of this
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athway whose activation by growth factors works synergisti-
ally with the glucocorticoid stimulus to sustain Na+ absorption
y preventing ENaC subunit ubiquitylation and clearance through
he Nedd4/2 pathway [111]. Watt et al. [112] used a new gener-
tion of selective kinase inhibitors to dissect this relationship and
ound that sequential inhibition of PI3K (PI103), SGK1 (GSK650394)
nd mTORC2 (TORIN1) abolished the growth factor-(insulin) and
lucocorticoid-induced Na+ current whereas short-term mTORC1
nhibition with rapamycin had no effect. Further analysis revealed
hat TORIN1 effectively abolished Akt/PKB and SGK1 phosphory-
ation at S473/T308 and S422 respectively, unveiling an exclusive
equirement for mTORC2 in the signalling cascade that links PI3K
o SGK1 and ENaC membrane recruitment. Similar mTORC2 con-
rol over SGK1 and Na+ conductance has been reported in kidney
lthough, here, mTORC1 also regulates ENaC subunit abundance
y controlling the translation of ENaC transcripts [113,114]. Fig. 4
ummarises the distinct roles of the mTOR complexes in control-
ing ENaC expression and membrane recruitment. By transducing
he endocrine signals which determine ﬂuid absorption capacity in
he lung and other epithelial tissues, the mTOR complexes, and in
articular, mTORC2, play key permissive roles in controlling events
ssential for postnatal life.
. Perspective and conclusions
mTOR complexes 1 and 2 beautifully ﬁt Brailsford-Robertson’s
oncept of a nutrient-sensitive “autocatakinetic” regulator of foetal
rowth. Maternal mTORC1 drives translation during the ﬁrst cleav-
ge steps of early embryonic life with newly expressed foetal
TORC1 taking over at the blastocyst stage to deﬁne the behaviour
f cells in the stem cell niche. Foetal mTORC1 also establishes
he placenta as the ﬁrst developmental organ of nutrient and gas
xchange and lays the structural foundations for organogenesis
uring gastrulation. In the formation of complex structures such
s the lung, mTORC1 regulates patterns of tissue growth within
he branching morphogenesis programme and is a contributing
actor in the molecular timing mechanism that establishes the frac-
al pattern of the airways. Through its varied interactions with
he HIF signalling pathway, mTORC1 links the growth of the pul-
onary vascular network to the airway branching morphogenesis
rogramme and so maintains a continuum of nutrient supply to
he growing regions of the lung. As the foetus approaches full term,
TORC2 establishes the conditions for ﬂuid withdrawal from the
ung so that the ﬁrst breaths of life can take place in the moments
ollowing birth. Far from being “deﬁnitely out of court” as Needham
ut it, to extend his tennis analogy, mTOR signalling lays out the
itch, selects the players and umpires play over the net as condi-
ions vary around the court. mTOR is a master regulator of tissue
rowth and organ complexity at all stages of foetal life.
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